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THE introduction of the toxic analogues ofpteroylglutamic acid in the treat-
ment of human leukaemias reported first by Farber, Diamond, Mercer, Sylvester
and Wolff (1948), and subsequently by many other workers, has led to an exten-
sive investigation of the properties of these compounds. The rather scanty
information which was at first available to afford theoretical support for the
rationale of this treatment has become expanded into a literature of considerable
proportion. Burchenal and his associates (1951) and Petering (1952) have
reviewed the more important investigations into the properties ofpteroylglutamic
acid analogues and quote references to the work which has substantially reduced
theempiricism ofthischemotherapeuticapproach. Althoughmuchenthusiasmhas
been developed for the antineoplastic potentialities of these compounds, their
usefulness in treatment has been greatly limited bytheir extreme toxicity, perhaps
the most striking of their properties. Their application is being increasingly
restricted on this account.
The very poisonous character of these drugs has received much detailed con-
sideration in the clinical context, but in common with other toxic drugs used in
this field, less theoretical attention has been directed towards the problems con-
nected with the assessment of their usefulness than would seem to be justified
in view of the importance of this aspect of chemotherapy. In the great bulk of
experimental work, 4-amino-N10 methyl pteroylglutamic acid (amethopterin) and
4-amino pteroylglutamic acid (aminopterin) have been used. The former, being
some ten times less toxic than aminopterin (Ferguson, Thiersch and Philips, 1950),
has been used in the work reported here.
Sugiura, Moore and Stock (1949) reported that aminopterin produced growth
retardation of a transplanted sarcoma, an adenocarcinoma and a melanoma in
mice, and noted that inhibition only occurred at toxic levels of dosage. It was
suggested, nevertheless, that this association between the tumour retarding effect
and the toxicity was compatible with the view that aminopterin had a definite
effect against tumour tissue. Schoenbach, Goldin, Goldberg and Ortega (1949)
have also reported growth regressions of Sarcoma 180 in response to aminopterin
and observed that body weight losses of up to 20 per cent were sustained by the
mice, but concluded from the greater percentage loss sustained by the tumours
that the drug was acting selectively. Moore, Stock, Sugiura and Rhoads (1949)
obtained inhibition of the growth of Sarcoma 180 using amethopterin and noted
the association between toxicity and tumour growth retardation. The importance
of this was not believed to be great enough to modify the conclusion that the
compound was a powerful inhibitor of the growth of this tumour. The evidence
presented here, though necessarily circumstantial, supports the contention that
most ofthe anti-neoplastic activity ofamethopterin for Sarcoma 180 and SarcomaJ. G. BENNETTE
37 is the result of an unselective toxic state induced as a result of treatment in
the animals carrying the tumours. The sex difference in toxicity reported by
Goldin, Greenspan, Goldberg and Schoenbach (1950) was confirmed and it was
noted in preliminary experiments that tumour growth retardation was obtained
only in tumours carried by the male mice which also showed a lower tolerance
to the drug. It was decided to investigate this sex difference in order to discover
whether the difference in the growth of the tumours between the sexes was a
function of the sex of the host acting by enhancing the effect of the drug on the
tumour or whether it was due to a secondary effect caused only by the different
susceptibility to intoxication.
MATERIALS AND METHODS.
The mice used throughout were mixed strain albinos obtained from reliable
dealers and used when they had attained a body weight of between 25 and 30 g.
They were housed in an air-conditioned atmosphere, the temperature of which
was maintained at 24 ! 4° C. Wire cages of a size comfortably to accommodate
20 mice were fitted with wire floors carrying bent wire feet so that the cages were
raised about 2 cm. above the level of the metal trays in which they were placed.
Each tray was lined with a sheet of absorbent paper. Water was supplied ad lib.
from bottles fitted with long stems which reached to within 2 cm. of the floors of
the cages. The rat cake used had the following composition:
Moisture . . . . . . 14 3 per cent.
Soluble carbohydrate . . . . 53.4 ,,
Protein . . . . . . . 200 ,,
Fat . . . . . . . 38 ,,
Fibre . . . . . . 3.3 ,,
Ash . . . . . . . 52 ,,
It was finely ground in a mill and dried at 37° C. for 24 hours in a thin layer.
The degree of desiccation obtained in this way was found to be such that there
was a negligible alteration in the water content of the ground food when this was
exposed to the conditions existing in a cage of mice for 24 hours. A weighed
excess of the food was given to the mice in a suitable arrangement of 2 oz. and
4 oz. glass ointment jars fitted with metal screw caps in each of which a circular
hole, 3 cm. in diameter, had been cut to allow access to the food. On the surface
ofthe food was placed a wire grille ofsuch a size that it easily fell in the jar as the
food was eaten, but could not be pulled through the hole in the screw cap. This
arrangement made it easy for the mice to reach and eat the food, but difficult for
them to scatter more than a small amount. Contamination of the food in the
jars was rarely seen and was always trivial in extent. Any food which was
scattered was collected on the paper on which the cage rested. The jars were
filled each day at the same time and the food remaining in them was weighed.
The papers contaminated with urine, faeces and scattered food, were collected
and dried in the air for 4 days, after which time the scattered food was separated
from the faeces by rubbing the mixture through a 12-mesh sieve. Though tedious
and rather distasteful, no real difficulty was encountered in making a complete
separation. The food consumption was then obtained by difference. All the
weighings offood were recorded to the nearest 0.25 g.
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The mice were grouped according to weight so that in any one cage the weights
varied from one another by no more than 3 g. The animals were weighed indi-
vidually to the nearest0.25 g. every other day throughout the experiment. They
were allowed to become accustomed to life in a cage without shavings for one
week before the experiment was started, when weighing of the food and the mice
was begun and continued until the food intake was found to have become stabi-
lized. At this point a selection was made in order to reduce the scatter among
the body weights of the individuals in a cage. The extremes of weight were
rejected and of the remaining animals exchanges were made between the cages
if this would increase the uniformity. Implantation was done 2 days later.
Two sarcomas were used, Sarcoma 37 and Sarcoma 180. Sarcoma 37 was
originally obtained from the Chester Beatty Research Institute of the Royal
Cancer Hospital, and has been perpetuated in this laboratory for several years
by serial implantation. Sarcoma 180 was obtained from the Sloan-Kettering
Institute ofNew York through the courtesy ofDr. C. Chester Stock. This tumour
was descended from the original Crocker Sarcoma 180. It was obtained from the
United States after a series of ambiguous experiments with Sarcoma 37 had raised
the possibility that this latter tumour might be resistant to the action ofamethop-
terin.
Implantation of the Sarcoma 180 was done by the trocar-cannula method.
Sarcoma 37 was implanted aseptically from a micrometer syringe by the method
described elsewhere (Bennette, 1952). In every case 0.04 ml. of tumour mince
suspension in0.9 per cent NaCl was injected from a No. 14 needle subcutaneously
into the right flank. In any one experiment all the mice were implanted with
the same homogeneous tumour mince prepared by the method of Craigie (1949a)
in a pressure mincer fitted with two plungers with groove depths ofapproximately
0.5 and 0.125 mm. In Experiments 1-4, a 50 per cent (v/v) mince suspension
in saline was used.
Treatment was started 6 days after implantation in Experiments 1 and 2,
and 10 days after implantation in Experiments 3 and 4. The sample ofamethop-
terin used was obtained from Lederle Laboratories through the courtesy of Dr.
T. H. Jukes. It was of tested purity. In all the experiments reported, solutions
containing 12 mg. per cent (w/v) of amethopterin were made up freshly each
day in sterile 0-1M NaH2PO4: Na2HPO4 buffer at pH 7.8 and were stored at 0° C.
Control animals received the same phosphate buffer alone. The volumes of the
doses given, representing about 0.3 per cent of the body weight of the mice, were
varied according to the mean weights of the groups so that the dose per kg. should
be as nearly as possible the same for two groups of actifferent mean body weight.
At a site removed from the place of implantation, subcutaneous injections were
given at 8-hourly intervals in accordance with the findings of the toxicity experi-
ments.
At the end ofthe experiments surviving mice were killed and the tumours dis-
sected out and examined for areas of necrosis, the degree of adherence to sur-
rounding structures, the presence ofulceration and the vascularity. The growths
were weighed wet to the nearest 10 mg. Systematic histological examination was
not done in this series of experiments.
In Experiment 5, the procedure was identical to that described above except
in the following respects. At the time of implantation, half the number of mice
in each cage were distinguished from the rest so as to provide a total of 16 groups.
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Control and experimental sets for each sex were implanted with the standard
volume oftumour mince suspensions at the following dilutions (v/v): 10-10°: 10-1'5
10-2'°: 10-2'5. Treatment was started 2 days after implantation. The appear-
ance and development of progressively growing tumours were recorded for 19
days after implantation, during which time food intake and body weight records
were made. When the mean body weights of the experimental groups showed
that recovery from the effects of treatment was well established, food intake
and body weight records were discontinued and the mice bearing tumours were
killed. Those mice with no palpable tumours were kept under observation for
another 23 days, after which it was assumed that no further tumours would
appear and the animals were killed. The tumours were not weighed or subjected
to post-mortem examination since it was the appearance of the growths and not
the character of their subsequent development which was important in this
experiment. The mice which died as a result oftreatment were examined for the
presence of tumours. Those which bore tumours were included in the analysis
while those which showed no sign of a tumour were excluded.
Toxicity.
Details of the toxicity experiments are not presented. The findings of Fer-
guson, Thiersch and Philips (1950) were repeated. It was found that the tolerance
was markedly reduced when the total dose was progressively fractionated. Thus,
when the drug was given daily, the total dose tolerated was more than double
that producing an equivalent condition of intoxication when the injections were
given 8-hourly. The individual variation in the response of albino mice was
considerable when the drug was given once daily, even in groups carefully selected
for weight uniformity. This variation was substantially reduced by giving the
injections three times a day. Reports of the rapid excretion of pteroylglutamic
acid analogues quoted by Burchenal et al. (1951) and the findings of Swenseid,
Swanson, Miller and Bethell (1950) support the view that the maintenance of an
effective blood level would be favoured by reducing the intervals between injec-
tions. The subcutaneous route was chosen for the same reason.
CALCULATION AND INTERPRETATION OF RESULTS.
The mice comprising some of the control and all of the experimental groups
were housed in more than one cage, and since it was necessary to make selections
in order to reduce the scatter among the individual body weights of the animals,
it was not possible to regard the groups as constituting a single population. The
body weight curves were accordingly calculated for each cage separately and then
t-tested one against the other. In most cases no significant difference was found
and grouping was therefore possible. In the following sets however-Experiment
2 female experimental: Experiment 4 male experimental: Experiment 5, male
control-small but significant differences were found between the body weight
curves derived from different cages. In each case the displaced curves pursued
courses roughly parallel to the others up to the time of treatment, and it was
considered likely that a simple procedure for making a correction for the displace-
ment could be justified. The mean difference between corresponding points on
the curves was obtained and the assumption that this value represented the
extent of a simple displacement of the origin was tested by repeating the t-test
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on the pairs ofpoints obtained by appropriately adding or subtracting the mean
difference. No significant difference was found in any of the instances after the
correction had been made and it was considered unnecessary to do a full analysis
ofcovariance. Having obtained single curves for the grouped controlandgrouped
experimental sets for each experiment, these were now tested for significant
difference up to the onset of treatment. In Experiment 3 (females) and Experi-
ment 5 (males and females) significant displacements were found to exist. These
were corrected for as has been described, the mean difference being added in each
case to the curve with the lower origin. As before the procedure was justified
by the finding that no significant differences existed after the corrections had been
made. The estimated terminal mean body weight values were corrected for the
presence of the tumours by subtracting the estimated mean tumour weights from
the terminal mean body weight values, and the body weight changes were ex-
pressed as percentage reductions on the mean control values. Since the control
tumours never reached such a size as to cause any obvious constitutional disturb-
ance in themice, it could be assumed fairly confidently that their presence had a
comparatively small effect on the body weight. The error due to the difference
in tumour sizes between control and experimental animals, if their presence were
responsible for a loss in body weight, would result in an understatement in the
percentage weight change obtained. The temporary depression or flattening of
the ascending weight curves of the control groups, corresponding to the period
of injections, may be taken to be due to the disturbance produced by the extra
handling involved. The body weight figures refer only to those mice which sur-
vived the experiments, including those described as moribund at the end. This
has been done in order to exclude the "effect of death" on the body weight, a
sudden profound terminal loss due to dehydration. In a few cases the moribund
mice may have been in this state, but the easy access to water would mean that
mice in an advanced toxic state would have to be virtually irmmobilized before
terminal dehydration could set in. Mice referred to as "moribund
" were those
within, say, 48 hours ofdeath-ruffled, unsteady and suffering in most cases from
diarrhoea which was haemorrhagic in some instances. A distinction is drawn
between the use of the words "moribund " and "dying." It was found in most
cases that a ruffled, unsteady mouse described as moribund would pass into an
agonal state in which it would become grossly ataxic and finally cease to be able
to move about the cage. The rate at which this sequence of events occurred was
rathervariable, and in order to account for this, an arbitrary correction was made
by excluding dying mice from the numbers of the groups on the day before their
death when calculating the food intake per mouse for that day. The food intake
figures were obtained from data relating to the whole group. The mean food
intake per mouse was calculated for each cage separately over 4-day periods,
and the results were subjected to the same analysis as that applied to the body
weight results. The procedure proved to be satisfactory in every case but one
(Experiment 3, females). In this group there were significant differences before,
during and after treatment, and these were not consistent. The result has been
recorded as of doubtful significance.
The quantitative estimates set down in Table I were derived from data for
which the values of the significance P were in every case less than 0.01. A less
exacting criterion of significance is regarded as being inappropriate in work of
this kind.
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Fig. 1 and 2 show the food intake and body weight curves in Experiments 3
and 2 respectively. The corresponding curves for Experiments 1 and 4 are
essentially the same. Since all the corresponding points have been t-tested, the
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FIG. 1.-Experiment 3. Sarcoma 37. Body weight and food intake.
Control group.
Treated group.
individual values for the standard errors about the means have been omitted from
the figures for the sake ofclarity.
In Experiments 1 and 3, the males and females received exactly the sameJ. G. BENNETTE
treatment and it is seen that it was only in the males that any important degree
of intoxication occurred and that tumour growth retardation likewise only
occurred to a significant extent in these groups. In Experiments 2 and 4 the does
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FIG. 2.-Experiment 2. Sarcoma 180. Body weight and food intake.------ Treated group.
Control group.
given to the females was increased and that given to the males decreased, with
the result that the females exhibited the manifestations of toxicity and also
showed a retardation of the growth of the tumours they carried. The males
showed no such changes to any important extent. For the males, a 20 per cent
reduction in the total dose producing intoxication and tumour growth retardation
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failed to produce either to a significant degree. For the females the corresponding
figure was 23 per cent.
Micrococci andbeta-haemolytic streptococci were found to have contaminated
the minces used for implanting the tumours in Experiments 3, 4 and 5, in spite of
aseptic precautions. This problem was encountered by Warner and Gostling
(1950) and in common with these workers it is felt that while it is important to
check the degree of contamination, the presence of bacteria does not necessarily
invalidate the results when experiments are adequately controlled.
No obviously consistent differences were found between the naked eye appear-
ances ofcontrol and experimental tumours and the records have not beenanalysed
in detail.
In Experiment 5, the 50 per cent end point ofthe "titration ' has been calcu-
lated by Thompson's method (1947), this being recommended by Armitage and
Allen (1950) as a reliable short-cut method in which the result can be expressed
within 95 per cent fiducial limits. The index used by Warner and Gostling
(1950) has not been calculated. Since the standard error ofthe difference between
the "tumour producing dose 50" (TPD50) for the control and experimental sets is
greater than the difference itself, the shifts in the end points as a result of treat-
ment at a toxic level of dosage cannot be regarded as significant.
DISCUSSION.
The results of Experiments 1 to 4 show that retardation of the tumours
Sarcoma 180 and Sarcoma 37 only occurs to an important extent when the hosts
are intoxicated by amethopterin to the point where about half the animals have
either died or passed into an advanced toxic state as a result of treatment under
the conditions stated. The question to be decided is the extent to which the action
of the drug can be regarded as selective in its effect upon the tumours. Lees and
Lees (1950) repeatedly found that non-specific toxic substances with low thera-
peutic ratios would bring about "significant" retardations of tumour growth.
One main purpose ofthis report is to submit an additional emphasis to the recom-
mendation made by these workers that any drug with a low therapeutic ratio
may be responsible for unjustifiable optimism as to its tumour retarding activity
ifthe basic considerations ofthe therapeutic ratio are not fully taken into account.
Rous (1914), Bischoff, Long and Maxwell (1935), Bischoff and Long (1938),
Tannenbaum (1947) and Goldin and his associates (1949) are among those who
have shown that the growth ofrecent implants is markedly affected by restriction
ofthe caloric intake. The problem ofdeciding between selective and unselective
toxicity has been approached by Goldin and his co-workers (1949) in experiments
with nitrogen mustards. These workers have studied the effect ofdietary restric-
tion on the growth ofSarcomna 180 and concluded from paired feeding experiments
that the weight loss incurred by the treated animals could account for the whole
of the tumour growth retardation observed in every case but one of a series of
toxic nitrogen mustards. By reference to a regression line relating the percen-
tage tumour weight and the percentage body weight loss, it was stated that only
29 per cent of the total tumour regression due to this one compound could be
attributed to a specific effect ofthe drug.
The use of a regression line as a means ofassessing the utility ofa toxic chemo-
therapeutic agent may be useful as a means of excluding compounds the toxicity
ofwhich is such that the body weight loss caused by their use can be shown to be
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sufficient to bring about the whole of the tumour growth retardation observed.
But where a retardation occurs which is greater than can be accounted for in this
way, the assertion that this residual activity is specific implies that body weight
loss is taken to be a completely satisfactory criterion of chronic toxicity. Paired
feeding experiments designed to establish regression lines for the tumours used in
the work reported here were not done because it is held that no single criterion is
adequate for the quantitative expression of chronic poisoning. Furthermore, it
cannot be assumed that information derived from calorie restriction experiments
can be applied directly to cases where the reduced food intake is the result of
anorexia due to slow poisoning, with all the complex metabolic disorder which
must occur in such a state. The use of a regression line as a means of making a
quantitative correctionforthe effectofcalorie restriction onthegrowthof a tumour
is felt to be oflittle use ifit remainsimpossible to have confidence that the residual
activity really represents a specific action on the part of the drug. If the effects
ofintoxication on the growth of a tumour cannot be separated from a supposedly
selective effect of the drug causing the intoxication, it must also be impossible to
apply the conventional approach ofchemotherapy to the study ofanimals bearing
tumours-that is, the attempt to enhance the specific action and reduce the
toxicity by correlating the biological activity with the chemical structure. On
theoretical grounds, then, it is submitted that the study of the effect of drugs on
the growth of tumours in animals is not profitable when the compounds are active
only at lethal or almost lethal levels. Such a conclusion is by no means original,
but no apology is offered for its restatement because it is clear that much careful
work continues to be done without full recognition of the fact that the results in
many instances cannot be interpreted unequivocally by reason of these con-
siderations.
The titration method used by Warner and Gostling (1950) was adopted as a
means ofinvestigating the effect ofamethopterin on the tumourproducing potency
of a mince ofSarcoma 37. Exposure of a dispersed implant to amethopterin at a
toxic level shortly after implantation was thought likely to represent a condition
in which the tumour cells would have the maximum susceptibility to damage.
The fact that no significant alteration in the estimated 50 per cent end point was
discovered is surprising in view of the findings of Tannenbaum (1947) relating to
the effect of calorie restriction on the early development of tumours. But the
failure by this method to demonstrate an action of the drug on the tumour cells
is not surprising in view of the failures reported in attempts to show a specific
action in vitro (Stock, Biesele, Burchenal, Karnofsky, Moore and Sugiura, 1950).
The titration method has the advantage of overcoming many of the difficulties
inherent in the quantitative evaluation oftumour growth in terms ofgrowth rate.
Its applicability to experimental cancer chemotherapyis being investigated. The
criticism of the method advanced by Craigie (1949b) has been noted. It would
appear that the objection applies more particularly to cases where comparisons
areattemptedbetween experiments inwhichdifference minceshave beenprepared.
The negative result ofExperiment 5 taken in conjunction with the fact that a
reduction by one fifth of a toxic and tumour retarding dose produces neither
tumour inhibition nor signs of toxicity under the conditions of the experiments
is taken to indicate that the association between toxicity and tumour inhibition
is too close to make it possible to place any reliance on the selectivity of the
tumour retarding effect of amethopterin for the transplanted Sarcomas 37 and
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180. The difference between the conclusion reached here and that given by other
workers in this field, notably Stock and his associates (1950), seems likely to be due
essentially to the fact that the use of an 8-hourly treatment procedure made it
possible to work in the neighbourhood of the extreme limit of tolerance to the
drug and to define more narrowly the conditions prevailing at the toxic and just
subtoxic levels of dosage. The possibility cannot be overlooked that tumour
tissue might be selectively damaged when exposed to higher concentrations of
amethopterin intermittently while it is resistant to a more continuous exposure to
lower concentrations, such as would be produced by more frequent injections.
SUMMARY.
Experiments have been described in which the tumour retarding action of
4-amino-N10 methyl pteroylglutamic acid (amethopterin) in mice has been related
to the toxic state induced in the animals as a result of treatment. The degree of
chronic intoxication has been judged by the food intake and body weight changes
which occur. The conclusion has been reached that the anti-neoplastic activity
of the drug is so closely associated with manifestations of toxicity that no con-
fidence can be placed in the selectivity of its action against the two transplanted
sarcomas studied. The sex difference in toxicity has been confirmed and the
failure to obtain a significant retardation of tumour growth except at the toxic
levels ofdosage for the two sexes supports the conclusion that the retardation is,
to a great extent at least, the result of an unselective poisoning. Some of the
problems connected with the evaluation of toxic chemotherapeutic agents in this
field have been discussed.
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